BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview
LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Return on Equity

Latest ROE for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028): -86.78% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-86.78%

Return on Equity

-86.78%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (YSBPW) FAQ

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s return on equity stands at -86.78%. That is below the sector sector average of -5.68%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) sits lower the its sector benchmark (-5.68%) with a ROE of -86.78%. That is roughly 1427.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of -86.78% for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s ROE evolved across reporting periods, while the comparison chart places YSBPW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.